Example: Heart Attack
Clinical Trials on Glabellar Crease
Total 10000 results
-
NCT00802945Completed
-
NCT02167932Completed
-
NCT02860104UnknownNeoplasm of Breast
-
NCT02865304UnknownBreast Cancer | Angiogenesis
-
NCT00327743CompletedCancer | Breast Cancer
-
NCT01384526CompletedBreast Cancer | Fertility
-
NCT02312700UnknownBreast Cancer | Empowerment
-
NCT01908270CompletedBreast Cancer | Menopause
-
-
NCT07075679RecruitingBreast Cancer Screening | Breast Cancer Screening and Diagnosis | Artificial Intelligence (AI)
-
NCT04768426RecruitingBreast Cancer | Triple Negative Breast Cancer
-
NCT02734290Active, not recruitingTriple Negative Breast Cancer
-
NCT06821490Enrolling by invitationHER2 Positive Breast Carcinoma | Breast Carcinoma Metastatic in Lymph Node
-
NCT07042737Not yet recruitingMotivation | Menopausal Women | Breast Cancer Females | Screening Strategy | Education Nursing
-
NCT06832202RecruitingHER2-low Hormone Receptor Positive Breast Cancer
-
NCT05560308Not yet recruitingHER2+ Advanced Breast Cancer Patients Progressing on TKI Therapy
-
NCT04986579RecruitingMetastatic Breast Cancer | Chemotherapy-induced Alopecia
-
NCT04911699Not yet recruitingSymptom Distress During Breast Cancer Treatment
-
NCT04546009Active, not recruitingEstrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer
-
-
NCT04576455Active, not recruitingEstrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer
-
NCT01996046Active, not recruitingBone Metastases | Estrogen Receptor Positive Breast Cancer
-
NCT05716542CompletedBreast Cancer | Cancer of the Breast
-
NCT03407768CompletedBreast Cancer | Hormone Receptor Positive Tumor | Premenopausal Breast Cancer
-
NCT05149014CompletedHER2-positive Breast Cancer
-
NCT03612934CompletedQuality of Life | Breast Cancer | Palliative Care | Cancer, Breast
-
NCT02393105UnknownCarcinoma of Male Breast
-
NCT07506876RecruitingHER-2 Positive Breast Cancer | Breast Cancer - Infiltrating Ductal Carcinoma
-
NCT07497386RecruitingUnresectable Locally Recurrent Breast Cancer | Unresectable Locally Metastatic Breast Cancer
-
NCT07150208Not yet recruitingBreast Cancer With Brain Metastasis | HER2-low Expressing Breast Cancer
-
-
NCT06595563RecruitingHER2-positive Metastatic Breast Cancer | HER2-positive Advanced Breast Cancer
-
NCT04439396CompletedBreast Reconstruction | Breast Reduction
-
NCT07415200Not yet recruitingPostoperative Complications | Breast Cancer | Breast Cancer-Related Lymphedema
-
NCT06507033Not yet recruitingBreast Cancer Related Lymphedema
-
NCT06347068RecruitingBreast Cancer | Triple Negative Breast Cancer | Relapse | Resistant Cancer
-
NCT05601037RecruitingLymphedema, Breast Cancer
-
NCT05455619RecruitingMetastatic Breast Cancer | HR+/HER2-negative Breast Cancer
-
NCT04579029RecruitingBreast Cancer | Lymphedema
-
NCT04446494RecruitingBreast Cancer Related Lymphedema
-
NCT04328610Recruiting
-
NCT07132749Enrolling by invitationNEPA in Patients With HER2-positive or HER2-low Advanced Breast Cancer Treated With T-DXd (PRO-NEPA)Patients With HER2-positive Advanced Breast Cancer Treated With T-DXd | Patients With HER2-low Advanced Breast Cancer Treated With T-DXd
-
NCT07072780Completed
-
NCT04465253Completed
-
NCT02983071Active, not recruitingBreast Cancer | Breast Neoplasm | Carcinoma, Ductal, Breast
-
NCT02806817CompletedBreast Cancer | Early-Stage Breast Carcinoma | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
-
NCT03534570UnknownHeart Diseases | Breast Neoplasm Female | Radiotherapy Side Effect
-
NCT02726477UnknownBreast Cancer | Lymphedema
-
NCT01672125Unknown
-
NCT07542106Recruiting